HighTower Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-45,000
Closed -$5.85K 3977
2024
Q3
$5.85K Buy
+45,000
New +$222K ﹤0.01% 3584
2024
Q1
Sell
-5,000
Closed -$10.5K 3869
2023
Q4
$10.5K Buy
5,000
+4,913
+5,647% +$24.1K ﹤0.01% 3438
2023
Q3
$12K Sell
87
-89
-51% -$713 ﹤0.01% 3374
2023
Q2
$6.29K Sell
176
-14,924
-99% -$126K ﹤0.01% 3332
2023
Q1
$16.3K Buy
15,100
+15,050
+30,100% +$166K ﹤0.01% 3163
2022
Q4
$3.5K Buy
+50
New +$581 ﹤0.01% 3238
2022
Q3
Sell
-21,000
Closed -$19K 3300
2022
Q2
$19K Buy
+21,000
New +$378K ﹤0.01% 3003

Other funds holding MPT

HighTower Advisors's MPT Position: Q1 2026 in Review

HighTower Advisors reduced its Medical Properties Trust (MPT) stake by 6.2% in Q1 2026, selling an estimated $27K and leaving 78,654 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

HighTower Advisors first reported a position in MPT in Q2 2013 and has held it in 49 quarters since. The position peaked at $3.29M in Q1 2021. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • HighTower Advisors held 78,654 shares of Medical Properties Trust worth $364K as of Q1 2026.
  • HighTower Advisors sold 5,175 Medical Properties Trust shares in Q1 2026, an estimated $27K.
  • Medical Properties Trust made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2990 holding.
  • HighTower Advisors first reported a position in Medical Properties Trust in Q2 2013 and has held it in 49 quarters since.
  • HighTower Advisors's Medical Properties Trust position peaked at $3.29M in Q1 2021.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.